NR568 Week 8 Final Exam Due 22nd
December 2025 Complete Actual Exam
Questions 1- 100 NR568 Advanced
Pharmacology NR 568 Midterm and Finals
Examplify Online Proctored Exam Questions
and Answers | 100% Pass Guaranteed |
Graded A+
Part 1: General Pharmacology Principles (Questions 1-15)
1. A drug with a narrow therapeutic index requires careful monitoring
because:
A) It has a wide margin of safety
B) There is a small difference between the therapeutic dose and the toxic dose
C) It is poorly absorbed orally
D) It has a long half-life
Rationale: Narrow therapeutic index drugs have a small margin between the
effective dose and the toxic dose, requiring monitoring of serum drug levels (e.g.,
warfarin, digoxin, lithium, phenytoin).
2. The half-life of a drug is defined as the time it takes for:
A) The drug to reach peak concentration
B) The drug to be completely eliminated from the body
C) The plasma concentration of the drug to decrease by 50%
D) The drug to be absorbed into the bloodstream
,Rationale: Half-life (t½) is the time required for the plasma concentration of a
drug to reduce by 50%. It determines dosing intervals and time to steady state.
3. Steady state of a drug is typically achieved after approximately how many
half-lives?
A) 1-2 half-lives
B) 4-5 half-lives
C) 6-8 half-lives
D) 10 half-lives
Rationale: Steady state is reached after approximately 4-5 half-lives of regular
dosing, at which point drug accumulation equals drug elimination.
4. Which pharmacokinetic process refers to the movement of a drug from the
site of administration into the bloodstream?
A) Distribution
B) Absorption
C) Metabolism
D) Excretion
Rationale: Absorption is the process by which a drug moves from its
administration site (oral, IM, transdermal, etc.) into the systemic circulation.
5. The volume of distribution (Vd) of a drug represents:
A) The total amount of drug in the body
B) The apparent space into which a drug distributes
C) The rate of drug clearance
D) The degree of protein binding
,Rationale: Vd is a theoretical volume that relates the amount of drug in the body
to the plasma concentration. Large Vd indicates extensive tissue distribution; small
Vd indicates confinement to plasma.
6. A drug that is highly protein-bound (e.g., warfarin) will:
A) Have a large volume of distribution
B) Be more easily dialyzed
C) Have increased free drug concentration when displaced by another
protein-bound drug
D) Have rapid renal excretion
Rationale: Highly protein-bound drugs (warfarin, phenytoin, diazepam) can be
displaced by other drugs, increasing free (active) drug concentration and risk of
toxicity.
7. The CYP450 enzyme system is primarily responsible for:
A) Drug absorption from the GI tract
B) Phase I drug metabolism (oxidation, reduction, hydrolysis)
C) Drug excretion through the kidneys
D) Drug distribution to tissues
Rationale: The cytochrome P450 enzyme system (mainly in liver) is responsible
for Phase I metabolism, converting lipophilic drugs into more polar, water-soluble
metabolites for excretion.
8. Which of the following drugs is a potent inhibitor of CYP3A4?
A) Rifampin
B) Carbamazepine
C) Ketoconazole
D) St. John's Wort
, Rationale: Ketoconazole (azole antifungals) is a potent CYP3A4 inhibitor. Other
inhibitors include erythromycin, clarithromycin, and grapefruit juice. Inducers
include rifampin, carbamazepine, phenytoin, and St. John's Wort.
9. Drugs that induce CYP450 enzymes will cause which effect on other drugs
metabolized by those enzymes?
A) Increased serum concentrations and increased risk of toxicity
B) Decreased serum concentrations and decreased therapeutic effect
C) No change in serum concentrations
D) Increased absorption
Rationale: Enzyme inducers increase the rate of metabolism of other drugs,
reducing their serum concentrations and potentially decreasing their therapeutic
effect.
10. Creatinine clearance (CrCl) is used to estimate:
A) Liver function
B) Cardiac output
C) Renal function (glomerular filtration rate, GFR)
D) Pulmonary function
Rationale: Creatinine clearance is used to estimate GFR and thus renal function.
Many drugs (e.g., metformin, aminoglycosides, digoxin) require dose reduction in
patients with decreased CrCl.
11. Agonist drugs are defined as drugs that:
A) Block the action of endogenous neurotransmitters
B) Bind to receptors and produce a biological response
C) Have no effect on receptors
D) Inactivate enzymes
December 2025 Complete Actual Exam
Questions 1- 100 NR568 Advanced
Pharmacology NR 568 Midterm and Finals
Examplify Online Proctored Exam Questions
and Answers | 100% Pass Guaranteed |
Graded A+
Part 1: General Pharmacology Principles (Questions 1-15)
1. A drug with a narrow therapeutic index requires careful monitoring
because:
A) It has a wide margin of safety
B) There is a small difference between the therapeutic dose and the toxic dose
C) It is poorly absorbed orally
D) It has a long half-life
Rationale: Narrow therapeutic index drugs have a small margin between the
effective dose and the toxic dose, requiring monitoring of serum drug levels (e.g.,
warfarin, digoxin, lithium, phenytoin).
2. The half-life of a drug is defined as the time it takes for:
A) The drug to reach peak concentration
B) The drug to be completely eliminated from the body
C) The plasma concentration of the drug to decrease by 50%
D) The drug to be absorbed into the bloodstream
,Rationale: Half-life (t½) is the time required for the plasma concentration of a
drug to reduce by 50%. It determines dosing intervals and time to steady state.
3. Steady state of a drug is typically achieved after approximately how many
half-lives?
A) 1-2 half-lives
B) 4-5 half-lives
C) 6-8 half-lives
D) 10 half-lives
Rationale: Steady state is reached after approximately 4-5 half-lives of regular
dosing, at which point drug accumulation equals drug elimination.
4. Which pharmacokinetic process refers to the movement of a drug from the
site of administration into the bloodstream?
A) Distribution
B) Absorption
C) Metabolism
D) Excretion
Rationale: Absorption is the process by which a drug moves from its
administration site (oral, IM, transdermal, etc.) into the systemic circulation.
5. The volume of distribution (Vd) of a drug represents:
A) The total amount of drug in the body
B) The apparent space into which a drug distributes
C) The rate of drug clearance
D) The degree of protein binding
,Rationale: Vd is a theoretical volume that relates the amount of drug in the body
to the plasma concentration. Large Vd indicates extensive tissue distribution; small
Vd indicates confinement to plasma.
6. A drug that is highly protein-bound (e.g., warfarin) will:
A) Have a large volume of distribution
B) Be more easily dialyzed
C) Have increased free drug concentration when displaced by another
protein-bound drug
D) Have rapid renal excretion
Rationale: Highly protein-bound drugs (warfarin, phenytoin, diazepam) can be
displaced by other drugs, increasing free (active) drug concentration and risk of
toxicity.
7. The CYP450 enzyme system is primarily responsible for:
A) Drug absorption from the GI tract
B) Phase I drug metabolism (oxidation, reduction, hydrolysis)
C) Drug excretion through the kidneys
D) Drug distribution to tissues
Rationale: The cytochrome P450 enzyme system (mainly in liver) is responsible
for Phase I metabolism, converting lipophilic drugs into more polar, water-soluble
metabolites for excretion.
8. Which of the following drugs is a potent inhibitor of CYP3A4?
A) Rifampin
B) Carbamazepine
C) Ketoconazole
D) St. John's Wort
, Rationale: Ketoconazole (azole antifungals) is a potent CYP3A4 inhibitor. Other
inhibitors include erythromycin, clarithromycin, and grapefruit juice. Inducers
include rifampin, carbamazepine, phenytoin, and St. John's Wort.
9. Drugs that induce CYP450 enzymes will cause which effect on other drugs
metabolized by those enzymes?
A) Increased serum concentrations and increased risk of toxicity
B) Decreased serum concentrations and decreased therapeutic effect
C) No change in serum concentrations
D) Increased absorption
Rationale: Enzyme inducers increase the rate of metabolism of other drugs,
reducing their serum concentrations and potentially decreasing their therapeutic
effect.
10. Creatinine clearance (CrCl) is used to estimate:
A) Liver function
B) Cardiac output
C) Renal function (glomerular filtration rate, GFR)
D) Pulmonary function
Rationale: Creatinine clearance is used to estimate GFR and thus renal function.
Many drugs (e.g., metformin, aminoglycosides, digoxin) require dose reduction in
patients with decreased CrCl.
11. Agonist drugs are defined as drugs that:
A) Block the action of endogenous neurotransmitters
B) Bind to receptors and produce a biological response
C) Have no effect on receptors
D) Inactivate enzymes
